Ryosuke Imai
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 8
- Respiratory Support and Mechanisms 5
- Pleural and Pulmonary Diseases 5
- Lung Cancer Diagnosis and Treatment 4
-
- Long-Term Effects of COVID-19 3
- Co-authors
- Torahiko Jinta (20 shared papers)Naoki Nishimura (18 shared papers)Manabu Murakami (6 shared papers)Tomohide Tamura (12 shared papers)Atsushi Kitamura (14 shared papers)Takakazu Higuchi (1 shared paper)Shunichi Uchiyama (1 shared paper)Sadamu Okada (1 shared paper)
- Journals
- BMC Pulmonary Medicine (5 papers)CHEST Journal (2 papers)QJM (2 papers)American Journal of Transplantation (1 paper)Lung Cancer (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ryosuke Imai
46 papers receiving 279 citations
Peers
Comparison fields: 5 of 73
- Critical Care and Intensive Care Medicine 17
- Infectious Diseases 46
- Pulmonary and Respiratory Medicine 73
- Neurology 33
- Electrochemistry 10
Countries citing papers authored by Ryosuke Imai
This map shows the geographic impact of Ryosuke Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Imai more than expected).
Fields of papers citing papers by Ryosuke Imai
This network shows the impact of papers produced by Ryosuke Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Imai. The network helps show where Ryosuke Imai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryosuke Imai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 45 | |
| 2 | 2023 | 34 | |
| 3 | 2017 | 24 | |
| 4 | 2007 | 18 | |
| 5 | 2022 | 13 | |
| 6 | 2021 | 12 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 8 | |
| 10 | 2019 | 8 | |
| 11 | 2021 | 7 | |
| 12 | 2023 | 7 | |
| 13 | 2021 | 6 | |
| 14 | 2022 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2020 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2021 | 4 |
About Ryosuke Imai
Ryosuke Imai is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Epidemiology, Oncology and Physiology, having authored 53 papers that have together received 287 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Respiratory Support and Mechanisms (5 papers), Pleural and Pulmonary Diseases (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Inflammatory Myopathies and Dermatomyositis (3 papers), COVID-19 Clinical Research Studies (3 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (17 citations), Infectious Diseases (46 citations), Pulmonary and Respiratory Medicine (73 citations), Neurology (33 citations) and Electrochemistry (10 citations). Ryosuke Imai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Torahiko Jinta, Naoki Nishimura, Manabu Murakami, Tomohide Tamura, Atsushi Kitamura, Takakazu Higuchi, Shunichi Uchiyama, Sadamu Okada, Yasushi Hasebe and Yasuyuki Kurihara. Their work appears in journals such as BMC Pulmonary Medicine, CHEST Journal, QJM, American Journal of Transplantation and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.